Primer: Guangzhou Novaken Pharm (GNP HK) - Aug 2026
Note on Company Identification: The user requested a report on 'Guangzhou Novaken Pharm (GNP HK)'. However, our research indicates that...
Guangzhou Novaken Pharm (GNP HK): Synthetic Expert Call Transcript (26 Jul 2026)
Critical Funding Cliff: Guangzhou Novaken Pharm is facing a severe liquidity crisis. As of May 31, 2026, the company had just 102.6 million RMB...
IPO Databook: Guangzhou Novaken Pharm (HK) - Jul 2026
Founded in 2007, Guangzhou Novaken Pharm is a clinical-stage pharmaceutical company developing modified new drugs using alternative formulations...
No more insights